secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-07-12T23:59:59+00:00
Accession:  0001493152-23-024277
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma secures $65K convertible note and AU$230K loan; issues warrant for 15M shares
--------------------------------------------------------------------------------

- Entered securities purchase agreement with 1800 Diagonal Lending LLC for $65,000 convertible note at 8% interest, convertible at 65% of market price.
- Loan agreement with institutional investor for AU$230,000 at 10% interest, 3-year term; issued warrant for 15M shares at $0.01.
- Proceeds used to repay ~$143,000 convertible note in default; remaining for working capital.
- Convertible note maturity June 29, 2024; prepayment premiums range from 110% to 129%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223024277/0001493152-23-024277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223024277/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer